RenovaCare looks to use skin as ‘natural bioreactor’ to treat burns
A device that isolates and sprays a patient’s own stem cells onto serious burns could have significant implications in the organ regeneration industry, says developer RenovaCare.
A device that isolates and sprays a patient’s own stem cells onto serious burns could have significant implications in the organ regeneration industry, says developer RenovaCare.
The study will evaluate how critical biomarkers and cell-therapy cancer vaccines are impacted by temperature and transport packaging at deep frozen temperatures.
Congress has asked the US FDA for information on EpiPen generic submissions and processes in light of a series of price hikes by drugmaker Mylan.
Impax Laboratories has issued a voluntary recall for one lot of its Lamotrigine Orally Disintegrating Tablet due to incorrect labeling of its blister packs.
Catalent Q4 results
Catalent has more than doubled its biologics business since it went public in 2014, but the sector still represents less than 5% of the CDMO’s revenues.
As more Massachusetts companies reach clinical trials, demand for biomanufacturing services in the state is increasing, says report.